Company: FTII
Filing Date: 2025-04-09
Form Type: 10-K
Source: 0001641172-25-003384
Chunk: 288

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-04-09
Form: 10-K
Item: Item 14
Chunk 288
---
mation of the proposed Longevity Business Combination is subject to certain conditions as further described in the Merger Agreement.

In
connection with the execution of the Merger Agreement, the sole stockholder of Longevity (the “Voting Stockholder”) has entered
into a Voting and Support Agreement (the “Longevity Support Agreement”), pursuant to which the Voting Stockholder has agreed
to, among other things, (i) vote in favor of the Merger Agreement and the transactions contemplated thereby and (ii) be bound by certain
other covenants and agreements related to the Transactions. The Voting Stockholder holds sufficient shares of Longevity to cause the
approval of the Transactions on behalf of Longevity.

In
connection with the execution of the Merger Agreement, the Company, the Sponsor has entered into a Voting and Support Agreement (the
“Sponsor Support Agreement”). The Sponsor Support Agreement provides that the Sponsor agrees (i) to vote in favor of the
proposed transactions contemplated by the Merger Agreement, (ii) to appear at the purchaser special meeting for purposes of constituting
a quorum, (iii) to vote against any proposals that would materially impede the proposed transactions contemplated by the Merger Agreement,
(iv) to not redeem any shares of the Company’s Common Stock held by it that may be redeemed, and (v) to waive any adjustment to
the conversion ratio set forth in the Company’s amended and restated certificate of incorporation (as amended from time to time,
the “Charter”) with respect to shares of the Class B Common Stock of the Company held by the Sponsor, in each case, on the
terms and subject to the conditions set forth in the Sponsor Support Agreement.

On
September 20, 2024, the Company filed a Form 8-K with the SEC to report the Merger Agreement and other legal agreements relating to the
Longevity Business Combination.

On
February 14, 2025, the Company filed with the SEC an initial Form S-4 (Registration/Proxy Statement) regarding the Longevity Business
Combination. The Company’s S-4 can be accessed on the EDGAR section of the SEC’s website at www.sec.gov.

Liquidity
and Management’s Plans

At
December 31, 2024, the Company had cash of $56,768 and working capital deficit of $5,026,967.

At
December 31, 2023, the Company had cash of $17,578 and working capital